Skip to content
TopDivs

BMY Dividend Calculator

Bristol-Myers Squibb Company yields 3.99%, close to the 2.92% median across US dividend payers — a rate that is unremarkable in itself, which puts the weight on how reliably it is paid rather than on how large it is. The figures below convert it into cash at a range of investment sizes.

BMY paid $2.51 per share over the last twelve months on a quarterly schedule. Enter any amount below, or use the worked figures.

Your investment

BMY

Bristol-Myers Squibb Company

3.99%

yield

$62.86 per shareQuarterlyStock
$
10 years
11530

Dividend income

$10,000 in BMY pays you

$399.30

per year

Paid each quarter
$99.83
Monthly average
$33.28
Shares bought
159.08
Payments a year
4

Total over 10 years, taken as cash

$3,993.00

Reinvest instead →

Based on the trailing twelve-month dividend, assuming it stays flat. Payments are not guaranteed and can be cut or suspended at any time. Figures are before tax and exclude any change in the share price.

BMY dividend income by investment amount

Based on the current yield of 3.99%. Figures are before tax and assume the dividend stays at its present level.

Dividend income from BMY at a range of investment amounts.
InvestedPer yearPer paymentMonthly average
$1,000$39.93$9.98$3.33
$5,000$199.65$49.91$16.64
$10,000$399.30$99.83$33.28
$25,000$998.25$249.56$83.19
$50,000$1,996.50$499.13$166.38
$100,000$3,993.00$998.25$332.75

BMY with dividends reinvested

$10,000 in BMY, every dividend reinvested, holding the payment and share price flat. Deliberately conservative — most calculators assume years of uninterrupted growth, and that assumption drives most of the result.

After 10 years
$14,878

$13,993 taking the income as cash

After 20 years
$22,136

$17,986 taking the income as cash

After 30 years
$32,935

$21,979 taking the income as cash

Model BMY with dividend growth →

What makes up BMY's 3.99% yield

BMY paid $2.51 per share over the last twelve months against a share price of $62.86, which is where the 3.99% comes from. Special and one-off distributions are excluded from that figure — they do not recur, and including them would overstate every projection below.

A yield near the median tells you little on its own, so the number worth pairing it with is the payout ratio: at 0.55, roughly 55% of BMY's earnings are committed to the dividend and the remaining 45% is retained. Two companies on identical yields can sit at opposite ends of that range, and it is the difference between a payment with room to absorb a weak year and one without.

Healthcare dividends compete for the same cash as research spending, which is why yields in the sector are typically modest even at large companies. The sector-specific risk to the payment is patent expiry: revenue concentrated in one or two products can step down sharply rather than decline gradually.

When BMY pays, and what that changes

BMY pays quarterly, the standard schedule for US-listed payers, so the "per payment" column is one quarter of the annual figure and the "monthly average" column is a smoothed figure rather than a description of when cash arrives — nothing is paid in eight months of the year.

Each payment has an ex-dividend date, and it is the date that governs entitlement: shares bought on or after it do not carry that payment. BMY's full schedule and payment history are on its dividend page.

Is BMY's dividend covered by earnings?

BMY's payout ratio of 0.55 means roughly 55% of earnings go to the dividend, leaving the rest retained. A margin that size is what allows a payment to be maintained through a weaker year without being funded from borrowing.

Demand in this kind of business holds up across a cycle, so the earnings behind the ratio move less than the market's average and the figure is reasonably representative rather than a snapshot of a good year.

The figures hold the dividend flat. BMY has raised its payment in each of the last 4 years, which is a shorter record than the multi-decade streaks found among the longest-standing payers, and not yet long enough to have been tested across a full cycle.

BMY dividend calculator FAQ

How much does $10,000 in BMY pay in dividends?
At BMY's current yield of 3.99%, $10,000 pays about $399.30 a year — roughly $99.83 per payment, paid quarterly, or $33.28 a month averaged out.
What would BMY be worth after 10 years with dividends reinvested?
Reinvesting every dividend and assuming the payment and share price both stay flat, $10,000 in BMY would grow to about $14,878 after 10 years, against $13,993 if the income were taken as cash. That deliberately assumes no dividend growth — a real holding may do better or considerably worse.
How often does BMY pay dividends?
BMY pays quarterly — 4 payments a year — based on its actual payment history rather than an assumed schedule.
Is BMY's dividend guaranteed?
No. Dividends are discretionary and can be reduced or suspended at any time, and every figure here is a projection from the current yield rather than a forecast. Check BMY's full payment history before relying on any of it.

More on BMY

Bristol-Myers Squibb Company is a common stock trading at $62.86 per share, paying quarterly. — All figures before tax. Not financial advice.